federal_register: 2011-18562

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2011-18562 Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee-September 21, 2011 Notice This notice announces that a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) ("Committee") will be held on Wednesday, September 21, 2011. The Committee generally provides advice and recommendations concerning the adequacy of scientific evidence needed to determine whether certain medical items and services can be covered under the Medicare statute. This meeting will focus on the currently available evidence regarding antivascular endothelial growth factor (anti-VEGF) treatment of diabetic macular edema (DME). This meeting is open to the public in accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)). 2011-07-22 2011 7 https://www.federalregister.gov/documents/2011/07/22/2011-18562/medicare-program-meeting-of-the-medicare-evidence-development-and-coverage-advisory https://www.govinfo.gov/content/pkg/FR-2011-07-22/pdf/2011-18562.pdf Health and Human Services Department; Centers for Medicare & Medicaid Services 221,45 This notice announces that a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) ("Committee") will be held on Wednesday, September 21, 2011. The Committee generally provides advice and recommendations concerning...  

Links from other tables